2021年4月17日 · CONTENTS Pathophysiology Epidemiology Clinical features Laboratory abnormalities Differential diagnosis & evaluation Diagnostic criteria Management Supportive …

2021年4月19日 · IBCC – Neuroleptic Malignant Syndrome (NMS) April 19, 2021 by Josh Farkas 2 Comments. Neuroleptic malignant syndrome is rare, but this will be encountered in the ICU. …

2022年5月25日 · Parkinsonism-hyperpyrexia syndrome is essentially a form of neuroleptic malignant syndrome (NMS) that results from rapid discontinuation of therapy for Parkinson's …

2024年12月18日 · (1) NMS is a idiosyncratic reaction after prolonged exposure to neuroleptics or after withdrawal of a dopamine receptor agonist. (2) NMS usually develops over days or …

2018年1月4日 · Objective: To provide an overview of neuroleptic malignant syndrome (NMS) for the general practitioner with the most up-to-date information on etiology, workup, and …

Differential Diagnosis. Many medical conditions can mimic the presentation of NMS, with some of the more common being heat stroke, central nervous system (CNS) infections, toxic …

Background: Neuroleptic malignant syndrome requires prompt recognition for effective management, but there are no established diagnostic criteria. This is the first validation study …

1998年9月1日 · OBJECTIVE: Neuroleptic malignant syndrome is an uncommon side effect of antipsychotic medications characterized by severe rigidity, tremor, fever, altered mental status, …

NMS is a rare condition as reported in the two studies done in neurology and psychiatric units of teaching hospitals in India with an incidence of 1.40–1.41/1000 cases treated with …

2023年4月24日 · Neuroleptic malignant syndrome (NMS) is a life-threatening syndrome associated with the use of dopamine-receptor antagonist medications or with the rapid …